2021 Advanced Clean Transportation (ACT) Expo Agenda Announced, Early Bird Rates Ending
May 06, 2021 15:35 ET | Advanced Clean Transportation (ACT) Expo
SANTA MONICA, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Organizers of the ACT Expo, North America’s leading conference and expo for the latest advanced transportation technologies for commercial...
Nav_logo_color_lores.png
Smart Communications Announces SCALE Award Winners at INNOVATE 2021 Conference
May 06, 2021 09:00 ET | Smart Communications
LONDON and NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- Smart CommunicationsTM, a leading technology company focused on helping businesses engage in more meaningful customer conversations, today...
Cradlepoint_logo_copy-1024x535.jpg
Cradlepoint Launches Second-Generation 5G Product Portfolio at its Global Partner Summit Event
May 05, 2021 12:30 ET | Cradlepoint
BOISE, Idaho, May 05, 2021 (GLOBE NEWSWIRE) -- Cradlepoint, a global leader in cloud-delivered 4G and 5G wireless network edge solutions, today unveiled its second-generation 5G product portfolio at...
Longeverson.jpg
Longeveron Invited to Present at the Benzinga Global Small Cap Conference
May 05, 2021 09:00 ET | Longeveron
Longeveron recently announced positive results from a Phase 1 study of Lomecel-B in Alzheimer's disease, and the completion of two Phase 2 clinical trials evaluating the safety and efficacy of...
pliant_primarysubtitle_color_RGB.jpg
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 05, 2021 08:05 ET | Pliant Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel...
Intra-Cellular_Logo_RGB_ALT.jpg
Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
May 05, 2021 08:00 ET | Intra-Cellular Therapies Inc.
NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...
ProgenityLogo.jpg
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
May 05, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Amicus-logo.jpg
Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 24th Annual Meeting
May 05, 2021 07:00 ET | Amicus Therapeutics, Inc.
PHILADELPHIA, May 05, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the acceptance of two abstracts for presentation at the American Society of Gene & Cell Therapy...
Logo-3.png
MineralTree to Showcase AP Automation Capabilities for Medical Practice Organizations at MGMA 2021 Conference
May 04, 2021 08:00 ET | MineralTree, Inc.
CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- MineralTree, an Accounts Payable (AP) and payments automation solution provider will be a featured sponsor at the Medical Group Management...
Denali_T_Logo_02.jpg
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 01, 2021 09:00 ET | Denali Therapeutics Inc.
Treatment with BIIB122/DNL151 achieved robust reductions in biomarkers of target engagement and pathway engagement in healthy volunteers and patients with Parkinson’s diseaseBIIB122/DNL151...